Pharma is urged to do more to thwart the superbug crisis
Ed Silverman of STAT news reports on the results of the Antimicrobial Resistance Benchmark and companies’ efforts in developing new medicines to combat superbugs.
In this article, STAT news covers the actions companies are taking to limit AMR and where action is still needed.
“Some companies, however, say they maintain a commitment, but the foundation report is the first to attempt to evaluate these efforts.”
